Are you Dr. Vandendries?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 West St
Waltham, MA 02451Phone+1 781-434-4463
Summary
- Dr. Erik Vandendries, MD is an oncologist in Waltham, Massachusetts. He is currently licensed to practice medicine in Massachusetts.
Certifications & Licensure
- MA State Medical License 2000 - 2025
Publications & Presentations
PubMed
- Dose Optimization of Elranatamab to Mitigate the Risk of Cytokine Release Syndrome in Patients with Multiple Myeloma.Mohamed Elmeliegy, Andrea Viqueira, Erik Vandendries, Anne Hickman, Umberto Conte
Targeted Oncology. 2025-02-25 - Five-Year Real-World Safety of Inotuzumab Ozogamicin Before Hematopoietic Stem Cell Transplantation in B-Cell Precursor Acute Lymphoblastic Leukemia.Marcos de Lima, Partow Kebriaei, Francesco Lanza, Christina Cho, Gizelle Popradi
American Journal of Hematology. 2025-02-24 - 1 citationsA Novel Two-Part Mixture Model for the Incidence and Time Course of Cytokine Release Syndrome After Elranatamab Dosing in Multiple Myeloma Patients.Donald Irby, Jennifer Hibma, Mohamed Elmeliegy, Diane Wang, Erik Vandendries
Clinical Pharmacology and Therapeutics. 2025-02-16